SG Americas Securities
KITE

SG Americas Securities’s Kite Pharma, Inc. KITE Stock Holding History

SG Americas Securities’s Portfolio KITE Stock Details KITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-95,837
Closed -$17.2M – 3930
2017
Q3 		$17.2M Buy
+95,837
New +$13.4M 0.15% 94
2017
Q1 		– Sell
-32,413
Closed -$1.45M – 3724
2016
Q4 		$1.45M Buy
32,413
+4,624
+17% +$227K 0.01% 1096
2016
Q3 		$1.55M Sell
27,789
-56,957
-67% -$3.17M 0.02% 878
2016
Q2 		$4.24M Sell
84,746
-4,258
-5% -$209K 0.03% 451
2016
Q1 		$4.09M Buy
89,004
+3,454
+4% +$167K 0.03% 464
2015
Q4 		$5.27M Sell
85,550
-3,329
-4% -$234K 0.04% 366
2015
Q3 		$4.95M Buy
88,879
+45,442
+105% +$2.86M 0.03% 380
2015
Q2 		$2.65M Buy
43,437
+28,727
+195% +$1.64M 0.02% 597
2015
Q1 		$848K Sell
14,710
-1,338
-8% -$89.7K 0.01% 1219
2014
Q4 		$925K Buy
16,048
+11,248
+234% +$474K ﹤0.01% 1260
2014
Q3 		$137K Buy
+4,800
New +$119K ﹤0.01% 2207

SG Americas Securities's KITE Position: Q4 2017 in Review

SG Americas Securities sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 95,837 shares — an estimated $17.2M sold.

SG Americas Securities first reported a position in KITE in Q3 2014 and held it in 11 quarters. The position peaked at $17.2M in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

  • SG Americas Securities reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
  • SG Americas Securities sold 95,837 Kite Pharma, Inc. shares in Q4 2017, an estimated $17.2M.
  • SG Americas Securities first reported a position in Kite Pharma, Inc. in Q3 2014 and held it in 11 quarters.
  • SG Americas Securities's Kite Pharma, Inc. position peaked at $17.2M in Q3 2017.
  • 0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on SG Americas Securities's 13F filing for Q4 2017, filed 24 Jan 2018.